Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772]
1 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
2 Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
3 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: [email protected].
4 Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: [email protected].
5 Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: [email protected].